Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases—development and validation of the LabBM score

BACKGROUND: We aimed to investigate the potential of standard hematologic and serum biochemical parameters to provide an independent and substantial contribution to the prediction of survival in patients with newly diagnosed brain metastases (BM). METHODS: Hemoglobin, white blood cell count, platele...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Berghoff, Anna S, Wolpert, Fabian, Holland-Letz, Tim, Koller, Romina, Widhalm, Georg, Gatterbauer, Brigitte, Dieckmann, Karin, Birner, Peter, Bartsch, Rupert, Zielinski, Christoph C, Weller, Michael, Preusser, Matthias
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
Clinical Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5570252/
https://ncbi.nlm.nih.gov/pubmed/28096493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now290
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы